Orion Pharma Limited

DSE:ORIONPHARM Stock Report

Market Cap: ৳16.6b

Orion Pharma Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Zareen Karim

Chief executive officer

৳3.6m

Total compensation

CEO salary percentagen/a
CEO tenure4.4yrs
CEO ownership2.7%
Management average tenureno data
Board average tenure14.4yrs

Recent management updates

Recent updates


CEO

Zareen Karim (46 yo)

4.4yrs

Tenure

৳3,600,000

Compensation

Mrs. Zareen Karim serves as a Director of Orion Pharma Limited since 2010 and has been its Managing Director since January 8, 2020. Mrs. Karim serves as a Non-Executive Director of Orion Infusion Limited s...


Board Members

NamePositionTenureCompensationOwnership
Zareen Karim
MD & Director14.4yrs৳3.60m2.74%
BDT 455.3m
Md. Rahman
Independent Director6yrs৳120.00kno data
Mohammad Karim
Non-Executive Chairman40.4yrs৳60.00k15.18%
BDT 2.5b
Arzuda Karim
Non-Executive Director39.4yrs৳70.00k3.76%
BDT 625.2m
Hasina Begum
Non-Executive Director27.4yrs৳60.00kno data
Salman Karim
Non-Executive Director14.4yrs৳120.00k4.15%
BDT 689.3m
A. N. M. Kashem
Independent Director4.4yrs৳130.00kno data

14.4yrs

Average Tenure

67.5yo

Average Age

Experienced Board: ORIONPHARM's board of directors are seasoned and experienced ( 14.4 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.